Role of Cardiopulmonary Exercise Testing in People With Heart Failure With Preserved Ejection Fraction
NCT07394010 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2026-02-06
Summary
Heart failure affects 1-2% of the adult population. Up to half of these patients have apparently normal heart pumping function, known as heart failure with preserved ejection fraction (HFpEF). Because HFpEF typically occurs in elderly patients with multiple comorbidities, many different mechanisms could drive symptoms and life expectancy, and it has been difficult to find effective treatments that work for all. Symptoms of HFpEF occur during exertion. The current scoring system for the diagnosis of HFpEF is not able to identify the majority of people and the majority of people remain in the zone of diagnostic uncertainty; there is no definite follow-up strategy, thus people do not receive appropriate treatment. Also, the medications, prehabilitation, and rehabilitation services are not personalised.
To cater to these gaps in clinical practice, this study was set up to use Cardiopulmonary exercise testing (CPET) to understand the complexity of this disease. The investigators plan to recruit patients with clinical suspicion of HFpEF, referred to the Cardiology Department at Ulster Hospital, Belfast, UK. After screening the medical records of patients based on the inclusion and exclusion criteria, the investigators recruited 40 patients to undergo a cardiopulmonary exercise test. CPET parameters related to the heart, lungs and muscles were recorded in real time, as the patient exercised on the bike to maximal effort.
The CPET data were then analysed to answer the above-mentioned clinical gaps. To disseminate the findings, the investigators plan to present the results at scientific, clinical, and patient group meetings and publish the findings in medical journals, to reach a wide array of healthcare professionals and policymakers.
Conditions
- Heart Failure With Preserved Ejection Fraction (HFPEF)
Interventions
- OTHER
-
Cardiopulmonary Exercise Test
It is the gold standard for assessing cardiorespiratory fitness. It assesses the combined functional capacity of the multiple systems of the body.
Sponsors & Collaborators
-
Ulster Hospital, Northern Ireland
collaborator UNKNOWN -
University of Ulster
lead OTHER
Principal Investigators
-
Chris Bleakley, PhD · Ulster University, Belfast, UK
-
George Kernohan, PhD · Ulster University, Belfast, UK
-
Peter McKavanagh, MD, PhD · Ulster Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-01
- Primary Completion
- 2025-06-10
- Completion
- 2025-06-10
Countries
- United Kingdom
Study Locations
More Related Trials
-
Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of HFpEF
NCT02638961 ·Status: COMPLETED ·Phase: NA
-
Understanding and Treating Heart Failure With Preserved Ejection Fraction: Novel Mechanisms, Diagnostics and Potential Therapeutics
NCT02052804 ·Status: COMPLETED
-
Characterization of Heart Failure With Preserved Ejection Fraction
NCT03197350 ·Status: RECRUITING ·Phase: NA
-
Accelerated Pacing and Cardiac Filling Pressures During Exercise in Patients With Heart Failure With Preserved Ejection Fraction
NCT07270536 ·Status: RECRUITING ·Phase: NA
-
Retrospective Observational Analysis of a Cohort With Heart Failure With Preserved Ejection Fraction
NCT04233086 ·Status: COMPLETED
-
Staging Heart Failure With Preserved Ejection Fraction
NCT06931015 ·Status: NOT_YET_RECRUITING
-
Optimising Management of Patients With Heart Failure With Preserved Ejection Fraction in Primary Care
NCT03617848 ·Status: COMPLETED
-
UK Heart Failure With Preserved Ejection Fraction
NCT05441839 ·Status: RECRUITING
-
Clinical Characteristics and Predictors of Adverse Outcomes in HFpEF
NCT06228807 ·Status: COMPLETED
-
Value of Intense Phenotyping in Heart Failure With Preserved Ejection Fraction
NCT05479669 ·Status: RECRUITING
-
Use of Oxygen in Heart Failure With Preserved Ejection Fraction
NCT02949531 ·Status: COMPLETED ·Phase: PHASE2
-
Heart Failure and a Preserved Ejection Fraction
NCT00586833 ·Status: COMPLETED
-
The Heart Failure With Preserved Ejection Fraction (HFpEF) Pathophysiology Study.
NCT03186833 ·Status: COMPLETED
-
Apple-CPET Ted Rogers Understanding Exacerbations of Heart Failure
NCT05008692 ·Status: UNKNOWN
-
Predictors of Poor Prognosis in HFpEF
NCT06844032 ·Status: RECRUITING
-
Copenhagen Heart Failure With Preserved Ejection Fraction
NCT06685237 ·Status: RECRUITING
-
Assessment of Cardiac Functional Reserve in Heart Failure With Preserved Ejection Fraction (HF-PEF)
NCT00585806 ·Status: COMPLETED
-
Prediction of the Development of Heart Failure With Preserved Ejection Fraction
NCT04894968 ·Status: UNKNOWN
-
DevElopMent of Clinical PATHwaYs to the Diagnosis of Heart Failure With Preserved Ejection Fraction
NCT05792059 ·Status: UNKNOWN
-
Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
NCT06114498 ·Status: ACTIVE_NOT_RECRUITING
-
Association Between Coronary and Peripheral Vascular Injury in Heart Failure Patients With Preserved Ejection Fraction.
NCT05884346 ·Status: UNKNOWN ·Phase: NA
-
Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course and Prognosis
NCT07375433 ·Status: RECRUITING
-
Clinical Study of Active Intervention in High-risk HFpEF Patients
NCT06532019 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Classification of Heart Failure With Preserved Ejection Fraction
NCT01030991 ·Status: COMPLETED
-
Chemoreflex Sensitivity in HFpEF
NCT06309537 ·Status: NOT_YET_RECRUITING